# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Strong Buy and raises the price target from $151 ...
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $144 t...
DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.27 by 18.52...